633 related articles for article (PubMed ID: 15703421)
1. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
Dragun D; Müller DN; Bräsen JH; Fritsche L; Nieminen-Kelhä M; Dechend R; Kintscher U; Rudolph B; Hoebeke J; Eckert D; Mazak I; Plehm R; Schönemann C; Unger T; Budde K; Neumayer HH; Luft FC; Wallukat G
N Engl J Med; 2005 Feb; 352(6):558-69. PubMed ID: 15703421
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
Ansari MJ; Tinckam K; Chandraker A
N Engl J Med; 2005 May; 352(19):2027-8; author reply 2027-8. PubMed ID: 15892197
[No Abstract] [Full Text] [Related]
3. Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation.
Thway TM; Shlykov SG; Day MC; Sanborn BM; Gilstrap LC; Xia Y; Kellems RE
Circulation; 2004 Sep; 110(12):1612-9. PubMed ID: 15381659
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation.
Yang X; Wang F; Chang H; Zhang S; Yang L; Wang X; Cheng X; Zhang M; Ma XL; Liu H
J Hypertens; 2008 Aug; 26(8):1629-35. PubMed ID: 18622242
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against mesangial cells in a rat model of chronic renal allograft rejection.
Joosten SA; van Ham V; Borrias MC; van Kooten C; Paul LC
Nephrol Dial Transplant; 2005 Apr; 20(4):692-8. PubMed ID: 15701669
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of signal transduction during vascular smooth muscle cell proliferation induced by autoantibodies against angiotensin AT1 receptor from hypertension.
Sun YX; Zhang HY; Wei YM; Zhu F; Wang M; Liao YH
Chin Med J (Engl); 2008 Jan; 121(1):43-8. PubMed ID: 18208665
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.
Reinsmoen NL; Lai CH; Heidecke H; Haas M; Cao K; Ong G; Naim M; Wang Q; Mirocha J; Kahwaji J; Vo AA; Jordan SC; Dragun D
Transplantation; 2010 Dec; 90(12):1473-7. PubMed ID: 21030904
[TBL] [Abstract][Full Text] [Related]
8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
Hilbrands L; Hoitsma A; Wetzels J
N Engl J Med; 2005 May; 352(19):2027-8; author reply 2027-8. PubMed ID: 15888709
[No Abstract] [Full Text] [Related]
10. Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia.
Wallukat G; Neichel D; Nissen E; Homuth V; Luft FC
Can J Physiol Pharmacol; 2003 Feb; 81(2):79-83. PubMed ID: 12710518
[TBL] [Abstract][Full Text] [Related]
11. The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection.
Dragun D
Pediatr Nephrol; 2007 Jul; 22(7):911-4. PubMed ID: 17340146
[TBL] [Abstract][Full Text] [Related]
12. Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodies.
Lukitsch I; Kehr J; Chaykovska L; Wallukat G; Nieminen-Kelhä M; Batuman V; Dragun D; Gollasch M
Transplantation; 2012 Jul; 94(1):8-13. PubMed ID: 22691955
[TBL] [Abstract][Full Text] [Related]
13. C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies.
Fuss A; Hope CM; Deayton S; Bennett GD; Holdsworth R; Carroll RP; Coates PT
Nephrology (Carlton); 2015 Jul; 20(7):467-73. PubMed ID: 25726938
[TBL] [Abstract][Full Text] [Related]
14. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
15. Agonistic antibody-triggered stimulation of Angiotensin II type 1 receptor and renal allograft vascular pathology.
Dragun D
Nephrol Dial Transplant; 2007 Jul; 22(7):1819-22. PubMed ID: 17517802
[No Abstract] [Full Text] [Related]
16. Agonistic autoantibodies and rejection of renal allografts.
Ingelfinger JR
N Engl J Med; 2005 Feb; 352(6):617-9. PubMed ID: 15703427
[No Abstract] [Full Text] [Related]
17. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 1 receptor-dependent nuclear factor-kappaB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis.
Chan YC; Leung PS
J Pharmacol Exp Ther; 2007 Oct; 323(1):10-8. PubMed ID: 17616560
[TBL] [Abstract][Full Text] [Related]
19. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Zmonarski S; Protasiewicz M; Nowakowska B; Hałoń A; Chudoba P; Klinger M
Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
[TBL] [Abstract][Full Text] [Related]
20. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
